Market Overview:
The global home and alternate site infusion therapy market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of chronic diseases, rising geriatric population, and technological advancements in home infusion therapies. Based on type, the global home and alternate site infusion therapy market is segmented into chemotherapy, anti-infective therapies, immune therapy, general nursing services, and others. The chemotherapy segment is expected to account for the largest share of the global home and alternate site infusion therapy market in 2018. This segment is projected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030 due to increasing prevalence of cancer across the globe. Based on application, the global home and alternate site infusion therapy market is divided into residential care settings (homes), ambulatory infusion centers (AICs), hospitals & clinics (inpatient setting), long-term care facilities (LTCFs), other institutional settings including military establishments & prisons; as well as non-institutional or individual users such as patients receiving infusions at their residence or workplace). The AICs segment accounted for majority share of revenue generated by application segments in 2017 owing primarilyto growing demand for outpatient treatmentsand increase incidencesof lifestyle diseases such as diabetes mellitusand hypertension that require regular infusions/administrationof drugs over an extended period oftime .
Product Definition:
Home infusion therapy is the delivery of intravenous (IV) medications and other treatments to a person in their home. Alternate site infusion therapy is the delivery of IV medications and other treatments to a person through a vein in an arm or leg, other than through a vein in the hand or arm. Home and alternate site infusion therapies are important because they allow people to receive treatment while remaining at home, which may improve quality of life.
Chemotherapy:
Chemotherapy is a group of medical treatments used to treat cancer. Chemotherapies mainly focus on the immune system in an attempt to kill cancer cells. Some chemotherapy drugs may also damage healthy cells. Currently, there are two main types of chemotherapies: systemic and local (injectable). Local therapies usually only affect the area where the tumor is located while systemic therapies can target any part of the body.
Anti-infective Therapies:
Anti-infective therapies are the medications used to treat or prevent diseases caused by microorganisms such as bacteria, viruses, and fungi. The major types of anti-infective drugs include antibiotics, antifungals/fungicides, and antivirals. Anti-invectives are also known as antimicrobials; they work by destroying the ability of microbes to reproduce or infect human cells.
Global Anti-Infective Therapies.
Application Insights:
The residential segment held the largest share of over 70.0% in 2017. The growth can be attributed to an increase in the number of cancer patients opting for home and alternate site infusion therapy as it helps them maintain their normal routine without any hassles at home or while traveling. Moreover, a rise in incidences of chronic diseases like heart diseases, blood clots and diabetes is also expected to boost demand for these therapies during infusions at homes or residential places as they help patients remain independent and mobile.
Infusion pumps are used by healthcare professionals so that they can deliver drugs through an intravenous line at a constant rate no matter where the patient may be located within his/her house or apartment complex (ambulatory infusion centers). These pumps are battery-operated devices that require only electricity from a single outlet; hence, they have become popular among people living in apartments who cannot afford medical equipment rental fees on a daily basis (general nursing services).
Regional Analysis:
North America dominated the global home and alternate site infusion therapy market in 2016. The presence of well-established healthcare infrastructure, high adoption rate of advanced therapies, and favorable reimbursement policies are some factors attributing to its large share. In addition, increasing demand for palliative care services is also expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to improving healthcare facilities & infrastructure along with rising patient awareness regarding these therapies in emerging countries such as China & India. Moreover, an increase in government initiatives aimed at improving access of patients living outside major cities will boost regional market development during the estimated time span.
Growth Factors:
- Increasing incidence of chronic diseases: The prevalence of chronic diseases is increasing at an alarming rate across the globe. This is primarily attributed to the changing lifestyle and dietary habits of people. Home and alternate site infusion therapy helps in delivering medications and other treatments directly to the patient’s home, which reduces the need for hospitalization or clinic visits. This increases convenience for patients as well as healthcare providers, thereby driving market growth.
- Technological advancements: The home infusion therapy market is witnessing rapid technological advancements, with new products and devices being launched regularly. These innovations are helping to improve patient care by providing more accurate dosing, reducing treatment time, and improving safety features. This is resulting in increased adoption of home infusion therapies among patients worldwide, propelling market growth further.
Scope Of The Report
Report Attributes
Report Details
Report Title
Home and Alternate Site Infusion Therapy Market Research Report
By Type
Chemotherapy, Anti-infective Therapies, Immune Therapy, General Nursing Services, Others
By Application
Residential, Ambulatory Infusion Centers, Others
By Companies
Option Care Health, Coram CVS, UnitedHealth Group, HCA Healthcare, McLaren, CHI Health, Accredo Health, PharMerica, Cleveland Clinic
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
144
Number of Tables & Figures
101
Customization Available
Yes, the report can be customized as per your need.
Global Home and Alternate Site Infusion Therapy Market Report Segments:
The global Home and Alternate Site Infusion Therapy market is segmented on the basis of:
Types
Chemotherapy, Anti-infective Therapies, Immune Therapy, General Nursing Services, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Residential, Ambulatory Infusion Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Option Care Health
- Coram CVS
- UnitedHealth Group
- HCA Healthcare
- McLaren
- CHI Health
- Accredo Health
- PharMerica
- Cleveland Clinic
Highlights of The Home and Alternate Site Infusion Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chemotherapy
- Anti-infective Therapies
- Immune Therapy
- General Nursing Services
- Others
- By Application:
- Residential
- Ambulatory Infusion Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Home and Alternate Site Infusion Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Some of the major players in the home and alternate site infusion therapy market are Option Care Health, Coram CVS, UnitedHealth Group, HCA Healthcare, McLaren, CHI Health, Accredo Health, PharMerica, Cleveland Clinic.
The home and alternate site infusion therapy market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Home and Alternate Site Infusion Therapy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Home and Alternate Site Infusion Therapy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Home and Alternate Site Infusion Therapy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Home and Alternate Site Infusion Therapy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Home and Alternate Site Infusion Therapy Market Size & Forecast, 2018-2028
4.5.1 Home and Alternate Site Infusion Therapy Market Size and Y-o-Y Growth
4.5.2 Home and Alternate Site Infusion Therapy Market Absolute $ Opportunity
Chapter 5 Global Home and Alternate Site Infusion Therapy Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Home and Alternate Site Infusion Therapy Market Size Forecast by Type
5.2.1 Chemotherapy
5.2.2 Anti-infective Therapies
5.2.3 Immune Therapy
5.2.4 General Nursing Services
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Home and Alternate Site Infusion Therapy Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Home and Alternate Site Infusion Therapy Market Size Forecast by Applications
6.2.1 Residential
6.2.2 Ambulatory Infusion Centers
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Home and Alternate Site Infusion Therapy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Home and Alternate Site Infusion Therapy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Home and Alternate Site Infusion Therapy Analysis and Forecast
9.1 Introduction
9.2 North America Home and Alternate Site Infusion Therapy Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Home and Alternate Site Infusion Therapy Market Size Forecast by Type
9.6.1 Chemotherapy
9.6.2 Anti-infective Therapies
9.6.3 Immune Therapy
9.6.4 General Nursing Services
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Home and Alternate Site Infusion Therapy Market Size Forecast by Applications
9.10.1 Residential
9.10.2 Ambulatory Infusion Centers
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Home and Alternate Site Infusion Therapy Analysis and Forecast
10.1 Introduction
10.2 Europe Home and Alternate Site Infusion Therapy Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Home and Alternate Site Infusion Therapy Market Size Forecast by Type
10.6.1 Chemotherapy
10.6.2 Anti-infective Therapies
10.6.3 Immune Therapy
10.6.4 General Nursing Services
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Home and Alternate Site Infusion Therapy Market Size Forecast by Applications
10.10.1 Residential
10.10.2 Ambulatory Infusion Centers
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Home and Alternate Site Infusion Therapy Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Home and Alternate Site Infusion Therapy Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Home and Alternate Site Infusion Therapy Market Size Forecast by Type
11.6.1 Chemotherapy
11.6.2 Anti-infective Therapies
11.6.3 Immune Therapy
11.6.4 General Nursing Services
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Home and Alternate Site Infusion Therapy Market Size Forecast by Applications
11.10.1 Residential
11.10.2 Ambulatory Infusion Centers
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Home and Alternate Site Infusion Therapy Analysis and Forecast
12.1 Introduction
12.2 Latin America Home and Alternate Site Infusion Therapy Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Home and Alternate Site Infusion Therapy Market Size Forecast by Type
12.6.1 Chemotherapy
12.6.2 Anti-infective Therapies
12.6.3 Immune Therapy
12.6.4 General Nursing Services
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Home and Alternate Site Infusion Therapy Market Size Forecast by Applications
12.10.1 Residential
12.10.2 Ambulatory Infusion Centers
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Home and Alternate Site Infusion Therapy Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Home and Alternate Site Infusion Therapy Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Home and Alternate Site Infusion Therapy Market Size Forecast by Type
13.6.1 Chemotherapy
13.6.2 Anti-infective Therapies
13.6.3 Immune Therapy
13.6.4 General Nursing Services
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Home and Alternate Site Infusion Therapy Market Size Forecast by Applications
13.10.1 Residential
13.10.2 Ambulatory Infusion Centers
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Home and Alternate Site Infusion Therapy Market: Competitive Dashboard
14.2 Global Home and Alternate Site Infusion Therapy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Option Care Health
14.3.2 Coram CVS
14.3.3 UnitedHealth Group
14.3.4 HCA Healthcare
14.3.5 McLaren
14.3.6 CHI Health
14.3.7 Accredo Health
14.3.8 PharMerica
14.3.9 Cleveland Clinic
